Phoenix, which manages £269 billion ($330 billion), bought the stake on behalf of its with-profits funds, the insurer said in a statement on Friday. The tie up will allow Phoenix to invest alongside Hambro Perks in venture and growth capital.
Hambro Perks holds stakes in over 135 companies in Europe, the US and the Middle East across nine funds within new technologies, including fin-tech, healthcare, life sciences and environmental technologies.
James Mitchell, head of strategic partnerships at Phoenix Group ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.